摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-benzyl-4-methylthiobenzaldehyde imine | 385368-37-6

中文名称
——
中文别名
——
英文名称
N-benzyl-4-methylthiobenzaldehyde imine
英文别名
(4-CH3SC6H4)HC=N(CH2Ph);Benzenemethanamine, N-[[4-(methylthio)phenyl]methylene]-;N-benzyl-1-(4-methylsulfanylphenyl)methanimine
N-benzyl-4-methylthiobenzaldehyde imine化学式
CAS
385368-37-6
化学式
C15H15NS
mdl
——
分子量
241.357
InChiKey
JMBJPURHVKGHOK-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    373.0±35.0 °C(Predicted)
  • 密度:
    1.02±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.7
  • 重原子数:
    17
  • 可旋转键数:
    4
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.13
  • 拓扑面积:
    37.7
  • 氢给体数:
    0
  • 氢受体数:
    2

SDS

SDS:ec5566a8215d308415350a30dcb3c6c5
查看

反应信息

  • 作为反应物:
    参考文献:
    名称:
    Inhibition of the Human Proteasome by Imidazoline Scaffolds
    摘要:
    The proteasome has emerged as the primary target for the treatment of multiple myeloma. Unfortunately, nearly all patients develop resistance to competitive-type proteasome inhibitors such as bortezomib. Herein, we describe the optimization of noncompetitive proteasome inhibitors to yield derivatives that exhibit nanomolar potency (compound 49, IC50 130 nM) toward proteasome inhibition and overcome bortezomib resistance. These studies illustrate the feasibility of the development of noncompetitive proteasome inhibitors as additives and/or alternatives to competitive proteasome inhibitors.
    DOI:
    10.1021/jm400235r
点击查看最新优质反应信息

文献信息

  • A palladium-catalyzed synthesis of (hetero)aryl-substituted imidazoles from aryl halides, imines and carbon monoxide
    作者:Jevgenijs Tjutrins、Bruce A. Arndtsen
    DOI:10.1039/c6sc04371b
    日期:——
    We describe here a tandem catalytic route to prepare imidazoles in a single operation from aryl iodides, imines and CO. The reaction involves a catalytic carbonylation of aryl halides with imines to form 1,3-dipoles, which undergo spontaneous 1,3-dipolar cycloaddition. Overall, this offers an alternative to coupling reactions to construct the (hetero)aryl-imidazole motif, where variation of the building
    我们在这里描述了一种串联催化路线,通过单次操作由芳基碘化物、亚胺和CO制备咪唑。该反应涉及芳基卤化物与亚胺的催化羰基化形成1,3-偶极子,然后发生自发的1,3-偶极环加成反应。总体而言,这为构建(杂)芳基-咪唑基序的偶联反应提供了一种替代方案,其中结构单元的变化可以允许合成广泛的咪唑家族,并独立控制所有取代基。
  • A Palladium-Catalyzed Multicomponent Synthesis of Imidazolinium Salts and Imidazolines from Imines, Acid Chlorides, and Carbon Monoxide
    作者:Kraig Worrall、Boran Xu、Sébastien Bontemps、Bruce A. Arndtsen
    DOI:10.1021/jo101858d
    日期:2011.1.7
    imidazolinium carboxylates and imidazolines is described. The palladium catalyst [Pd(CH(R1)N(R2)COR3)Cl]2, or [Pd(allyl)Cl]2, with P(t-Bu)2(2-biphenyl) can mediate the simultaneous coupling of two imines, acid chloride, and carbon monoxide into substituted imidazolinium carboxylates within hours under mild conditions (45 °C, 4 atm of CO). The reaction proceeds in good yield with aryl-, heteroaryl-, and alkyl-substituted
    描述了钯催化的羧酸咪唑啉和咪唑啉的多组分合成。钯催化剂[Pd(CH(R 1)N(R 2)COR 3)Cl] 2或[Pd(烯丙基)Cl] 2,具有P(t- Bu)2(2-联苯)可以在温和条件下(45°C,4 atm CO)在数小时内将两个亚胺,酰氯和一氧化碳同时偶联到取代的咪唑啉代羧酸盐中。用芳基,杂芳基和烷基取代的酰氯,以及各种官能化的亚胺,反应以高收率进行。咪唑啉是通过最初生成的Münchnone中间体形成的,然后将它们与原位生成的质子化的亚胺环加成。胺碱的添加可以阻止Münchnone形成时的催化作用,从而允许随后的第二个亚胺的环加成反应。后者提供了一种复杂的,多取代的咪唑啉鎓羧酸盐的组装方法,并且可以独立控制所有五个取代基。
  • Multicomponent Synthesis of Substituted and Fused-Ring Imidazoles via Phospha-münchnone Cycloaddition
    作者:Sara Aly、Mikhail Romashko、Bruce A. Arndtsen
    DOI:10.1021/jo5028936
    日期:2015.3.6
    A new, one-pot synthesis of imidazoles from imines, acid chlorides, and N-nosyl imines or tethered nitriles is reported. The reaction is mediated by the phosphonite PPh(catechyl) and proceeds via regioselective cycloaddition with an in situ-generated phospha-münchnone 1,3-dipole. This provides an efficient route to construct both highly substituted and polycyclic imidazoles directly from available
    据报道,由亚胺,酰氯和N- nosyl亚胺或拴合的腈新合成一锅的咪唑。该反应由亚膦酸酯PPh(邻苯二甲酰基)介导,并通过区域选择性环加成反应与原位生成的膦-慕尼黑酮1,3-偶极进行。这提供了直接从可用的底物上构建高度取代的多环咪唑和多环咪唑的有效途径,而无需金属催化剂,并且能够获得产品的多样性。
  • Palladium catalyzed synthesis of indolizines <i>via</i> the carbonylative coupling of bromopyridines, imines and alkynes
    作者:Sébastien A. Roy、José Zgheib、Cuihan Zhou、Bruce A. Arndtsen
    DOI:10.1039/d0sc03977b
    日期:——
    We report herein the development of a palladium-catalyzed, multicomponent synthesis of indolizines. The reaction proceeds via the carbonylative formation of a high energy, mesoionic pyridine-based 1,3-dipole, which can undergo spontaneous cycloaddition with alkynes. Overall, this provides a route to prepare indolizines in a modular fashion from combinations of commercially available or easily generated
    我们在此报告了钯催化的中氮茚的多组分合成的发展。该反应通过羰基化形成高能介离子吡啶基 1,3-偶极子进行,该偶极子可以与炔烃自发环加成。总体而言,这提供了一种以模块化方式从市售或容易生成的试剂:2-溴吡啶、亚胺和炔烃的组合制备中氮茚的途径。
  • Inhibition of the Human Proteasome by Imidazoline Scaffolds
    作者:Lauren M. Azevedo、Theresa A. Lansdell、Jacob R. Ludwig、Robert A. Mosey、Daljinder K. Woloch、Dillon P. Cogan、Gregory P. Patten、Michael R. Kuszpit、Jason S. Fisk、Jetze J. Tepe
    DOI:10.1021/jm400235r
    日期:2013.7.25
    The proteasome has emerged as the primary target for the treatment of multiple myeloma. Unfortunately, nearly all patients develop resistance to competitive-type proteasome inhibitors such as bortezomib. Herein, we describe the optimization of noncompetitive proteasome inhibitors to yield derivatives that exhibit nanomolar potency (compound 49, IC50 130 nM) toward proteasome inhibition and overcome bortezomib resistance. These studies illustrate the feasibility of the development of noncompetitive proteasome inhibitors as additives and/or alternatives to competitive proteasome inhibitors.
查看更多